Pharmacological profile of antidepressants and related compounds at human monoamine transporters

European Journal of Pharmacology

Volumn 340, Issue 2-3, 1997, Pages 249-258

  Tatsumi, Masahiko ^a,b   Groshan, Karen ^a   Blakely, Randy D ^c   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) transporter, human; Antidepressant; Dopamine transporter, human; Norepinephrine transporter, human; Radioligand binding assay

Indexed keywords

ACETAZOLAMIDE; AMITRIPTYLINE; ANOREXIGENIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DOPAMINE TRANSPORTER; ESTRONE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MAZINDOL; METHYLPHENIDATE; MIRTAZAPINE; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; NOMIFENSINE; NORADRENALIN; NORSERTRALINE; PROTRIPTYLINE; SEROTONIN TRANSPORTER; UNINDEXED DRUG; VENLAFAXINE; VERAPAMIL; VILOXAZINE;

ARTICLE; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIDEPRESSIVE AGENTS; BRAIN; CARRIER PROTEINS; CELL LINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; RADIOLIGAND ASSAY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYMPORTERS; SYNAPTOSOMES;

EID: 0031565115     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01393-9     Document Type: Article

References (38)

1. Agnati L.F., Zoli M., Stromberg I., Fuxe K. Intercellular communication in the brain: wiring versus volume transmission. Neuroscience. 69:1995;711-726.
2. Barker E.L., Blakely R.D. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol. Pharmacol. 50:1996;957-965.
3. Barker E.L., Kimmel H.L., Blakely R.D. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol. Pharmacol. 46:1994;799-807.
4. Bolden-Watson C., Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 52:1993;1023-1029.
5. Brown N.L., Sirugue O., Worcel M. The effects of some slow channel blocking drugs on high affinity serotonin uptake by rat brain synaptosomes. Eur. J. Pharmacol. 123:1986;161-165.
6. 3H ]imipramine indicates the presence of a specific serotonin transport system on endothelial cells of porcine brain Neurosci. Lett. 194:1995;21-24.
7. Bylund, D.B., Yamamura, H.I., 1990. Methods for receptor binding. In: Yamamura, H.I., Enna, S.J., Kuhar, M.J. (Eds.), Methods in Neurotransmitter Receptor Analysis. Raven Press, New York, NY, pp. 1-35.
8. Carlsson A., Lindqvist M. Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J. Pharm. Pharmacol. 21:1969;460-464.
9. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
10. De Lean A., Hancock A.A., Lefkowitz R.J. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 21:1982;5-16.
11. Eshleman A.J., Neve R.L., Janowsky A., Neve K.A. Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharmacol. Exp. Ther. 274:1995;276-283.
12. Fleming W.W., Westfall D.P., De La Lande I.S., Jellett L.B. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181:1972;339-345.
13. 3H ]nisoxetine binding in rat brain J. Neurochem. 64:1995;2792-2800.
14. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
15. Glowinski J., Axelrod J. Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature. 204:1964;1318-1319.
16. Jayanthi L.D., Prasad P.D., Ramamoorthy S., Mahesh V.B., Leibach F.H., Ganapahy V. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. Biochemistry. 32:1993;12178-12185.
17. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:1976;649-661.
18. Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am. J. Psychiatry. 115:1958;459-464.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Maas J.W. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch. Gen. Psychiatry. 32:1975;1357-1361.
21. Madras B.K., Fahey M.A., Bergman J., Canfield D.R., Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. I. J. Pharmacol. Exp. Ther. 251:1989;131-141.
22. McGee R. Jr., Schneider J.E. Inhibition of high affinity synaptosomal uptake systems by verapamil. Mol. Pharmacol. 16:1979;877-885.
23. Munson P.J., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 107:1980;220-239.
24. 3H ]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine J. Neurochem. 54:1990;1275-1280.
25. Oxman T.E. Antidepressants and cognitive impairment in the elderly. J. Clin. Psychiatry. 57:1996;38-44.
26. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
27. Pfenning, M.A., Richelson, E., 1990. Methods for studying receptors with cultured cells of nervous tissue origin. In: Yamamura, H.I., Enna, S.J., Kuhar, M.J. (Eds.), Methods in Neurotransmitter Receptor Analysis. Raven Press, New York, pp. 147-175.
28. 3H ]GBR 12,935 binding Mol. Pharmacol. 45:1994;125-135.
29. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression and chromosomal localization. Proc. Natl. Acad. Sci. USA. 90:1993;2542-2546.
30. Reith M.E., Xu C., Zhang L., Coffey L.L. Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter. Naunyn Schmiedeberg's Arch. Pharmacol. 354:1996;295-304.
31. Richelson E. Pharmacology of antidepressants: Characteristics of the ideal drug. Mayo Clin. Proc. 69:1994;1069-1081.
32. Richelson E. Synaptic effects of antidepressants. J. Clin. Psychopharmacol. 16:1996;S1-S7.
33. Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
34. Ross S.B., Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 7:1969;270-277.
35. Shank R.P., Gardocki J.F., Schneider C.R., Vaught J.L., Setler P.E., Maryanoff B.E., McComsey D.F. Preclinical evaluation of McN-5707 as a potential antidepressant. J. Pharmacol. Exp. Ther. 242:1987;74-84.
36. 3H ]nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding J. Pharmacol. Exp. Ther. 260:1992;427-436.
37. 14C -5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis Naunyn Schmiedeberg's Arch. Pharmacol. 296:1976;59-65.
38. Young C.S., Mason R., Hill S.J. Inhibition by H1-antihistamines of the uptake of noradrenaline and 5-HT into rat brain synaptosomes. Biochem. Pharmacol. 37:1988;976-978.